We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+13.69%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$53.1B
AUM Growth
+$6.76B
(+15%)
Cap. Flow
+$2.33B
Cap. Flow
% of AUM
4.39%
Top 10 Holdings %
Top 10 Hldgs %
14.65%
Holding
2,220
New
169
Increased
729
Reduced
1,033
Closed
165
Avg Time Held
21.7
quarters
Top 10 Avg Time Held
6.6
quarters
Top 20 Avg Time Held
9.9
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zscaler
ZS
|
+$222M |
| 2 |
Palantir
PLTR
|
+$221M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$213M |
| 4 |
FirstEnergy
FE
|
+$189M |
| 5 |
Broadcom
AVGO
|
+$174M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$383M |
| 2 |
Philip Morris
PM
|
+$280M |
| 3 |
Entergy
ETR
|
+$207M |
| 4 |
Paychex
PAYX
|
+$206M |
| 5 |
Gilead Sciences
GILD
|
+$201M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.81% |
| 2 | Healthcare | 14.57% |
| 3 | Financials | 13.43% |
| 4 | Industrials | 10.29% |
| 5 | Consumer Discretionary | 9.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2026
DNOW Inc
DNOW
$2.81B
| $608 | ﹤0.01% |
41
-38
| -48% | -$580 |
2014 Q2
44 quarters
|
|
2027
First Bancorp
FBP
$4.07B
| $604 | ﹤0.01% |
29
-1,331
| -98% | -$26.2K |
2014 Q3
43 quarters
|
|
2028
Contango Silver & Gold Inc
CTGO
$559M
| $584 | ﹤0.01% |
+30
| New | +$483 |
2025 Q2
0 quarters
|
|
2029
Teekay
TK
$1.34B
| $561 | ﹤0.01% |
68
-66
| -49% | -$512 |
2023 Q4
6 quarters
|
|
2030
Rapid7
RPD
$926M
| $509 | ﹤0.01% |
+22
| New | +$522 |
2025 Q2
0 quarters
|
|
2031
SandRidge Energy
SD
$513M
| $509 | ﹤0.01% |
47
-10
| -18% | -$102 |
2024 Q2
4 quarters
|
|
2032
Hingham Institution for Saving
HIFS
$634M
| $497 | ﹤0.01% |
2
-1
| -33% | -$242 |
2024 Q4
2 quarters
|
|
|
MDV
2033
DELISTED
Modiv Industrial
MDV
| $479 | ﹤0.01% |
+34
| New | +$505 |
2025 Q2
0 quarters
|
|
2034
DELISTED
Enterprise Bancorp
EBTC
| $476 | ﹤0.01% |
12
-5
| -29% | -$191 |
2025 Q1
1 quarter
|
|
2035
Box
BOX
$4.99B
| $444 | ﹤0.01% |
13
-5,817
| -100% | -$191K |
2015 Q1
41 quarters
|
|
2036
Ferguson
FERG
$42.6B
| $436 | ﹤0.01% |
+2
| New | +$368 |
2025 Q2
0 quarters
|
|
2037
Village Super Market
VLGEA
$652M
| $424 | ﹤0.01% |
+11
| New | +$406 |
2025 Q2
0 quarters
|
|
2038
Greif Class B
GEF.B
$4.09B
| $414 | ﹤0.01% |
6
-2
| -25% | -$121 |
2024 Q4
2 quarters
|
|
2039
Triumph Financial Inc
TFIN
$1.49B
| $386 | ﹤0.01% |
7
-16
| -70% | -$891 |
2020 Q4
18 quarters
|
|
2040
Workiva
WK
$3.99B
| $342 | ﹤0.01% |
5
-24,332
| -100% | -$1.67M |
2022 Q4
10 quarters
|
|
2041
X4 Pharmaceuticals
XFOR
$289M
| $283 | ﹤0.01% |
+149
| New | +$610 |
2025 Q2
0 quarters
|
|
2042
NVE Corp
NVEC
$551M
| $221 | ﹤0.01% |
3
| – | – |
2017 Q1
33 quarters
|
|
2043
DELISTED
M-tron Industries Warrants
MPTI.WS
| $215 | ﹤0.01% |
+207
| New | +$237 |
2025 Q2
0 quarters
|
|
2044
Guardian Pharmacy Services
GRDN
$2.61B
| $213 | ﹤0.01% |
+10
| New | +$226 |
2025 Q2
0 quarters
|
|
2045
Sylvamo
SLVM
$1.3B
| $200 | ﹤0.01% |
4
-41,575
| -100% | -$2.34M |
2022 Q1
13 quarters
|
|
2046
REX American Resources
REX
$1.4B
| $195 | ﹤0.01% |
8
| – | – |
2013 Q3
47 quarters
|
|
2047
Pacific Biosciences
PACB
$724M
| $170 | ﹤0.01% |
137
-465,121
| -100% | -$537K |
2024 Q2
4 quarters
|
|
2048
Kodiak Gas Services
KGS
$5.41B
| $103 | ﹤0.01% |
3
-11,359
| -100% | -$393K |
2024 Q1
5 quarters
|
|
2049
1-800-Flowers.com
FLWS
$173M
| $64 | ﹤0.01% |
13
-81
| -86% | -$419 |
2022 Q2
12 quarters
|
|
2050
Organon & Co
OGN
$3.63B
| $48 | ﹤0.01% |
5
-83,937
| -100% | -$866K |
2021 Q2
16 quarters
|
|
Similar funds
Federated Hermes's Q2 2025 Portfolio in Review
As of Q2 2025, Federated Hermes held 2,220 positions worth $53.1B, up 15% from $46.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Federated Hermes deployed $2.33B of net new capital in Q2 2025, opening 169 new positions and adding to 729 existing holdings. Its largest new stake was Genuine Parts: 882,160 shares worth $107M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $383M trimmed.
- Federated Hermes's largest Q2 2025 buy was Genuine Parts: 882,160 shares worth $107M.
- Federated Hermes added most to Zscaler in Q2 2025, an estimated $222M increase.
- Federated Hermes's biggest Q2 2025 reduction was Bristol-Myers Squibb, cutting an estimated $383M.
- Federated Hermes fully exited Regulus Therapeutics in Q2 2025, selling an estimated $39.2M.
- Federated Hermes's ten largest holdings make up 15% of its $53.1B portfolio in Q2 2025.
- Federated Hermes opened 169 new positions and closed 165 in Q2 2025.
- Federated Hermes's portfolio value rose 15% quarter-over-quarter to $53.1B.
Based on Federated Hermes's 13F filing for Q2 2025, filed 13 Aug 2025.